COMBINE 2
Real-world evidence for effectiveness of Two Drug Regimen, Antiretroviral therapy with integrase inhibitors plus a reverse transcriptase inhibitor
Indication: Treatment naïve patients or switching option for patients with HIV RNA suppression on current treatment or second line treatment for patients with virological failure on prior treatment
Phase: IV
Sites:26
Territories : 6
Poster:
BHIVA 2022 - E-Poster Presentation
Title : History of drug resistance mutations and virologic outcomes for
Author : Cristina Mussini, Cassidy Henegar, Lambert Assoumou, Stephane De Wit, Margaret Johnson, Eugenia Quiros Roldan Carl Fletcher Annie Duffy Leigh Ragone Jean van Wyk 8 Michael Aboud Anton Pozniak Vani Vannappagari
EACS 2021 - E-Poster Presentation
Title : Highly Effective Two drug Regimens of an Integrase Inhibitor and Reverse Transcriptase Inhibitor in Real World Setting Data from COMBINE 2 Study
Author : Cristina Mussini, Cassidy Henegar, Lambert Assoumou, Stephane De Wit, 4 Margaret Johnson, Eugenia Quiros Roldan, Leigh Ragone, Jean van Wyk, Michael Aboud, Carl Fletcher, Annie Duffy, Anton Pozniak, Vani Vannappagari, on behalf of the COMBINE 2 Study Group
EACS 2023 - E-Poster Presentation
Title : Dolutegravir + lamivudine 2-drug regimen is highly effective and well-tolerated in a real-world clinical setting in Europe: data from the COMBINE-2 Study
Author : Cristina Mussini,1Cassidy Henegar,2Lambert Assoumou,3Stephane DeWit,4Margaret Johnson,5Eugenia Quiros Roldan,6Leigh Ragone,2Bryn Jones,7Jeanvan Wyk,7Michael Aboud,2Carl Fletcher,8Annie Duffy,8Selina Bannoo,8A. Pozniak,9Vani Vannappagari 2 on behalf of the COMBINE-2 Study Group
IAS 2024 - E-Poster Presentation
Title : Real-world observational study in Europe on the effectiveness and safety of two-drug regimens containing an integrase inhibitor and reverse transcriptase inhibitor (COMBINE-2): Week 96 stable switch population results
Author : Cristina Mussini, Cassidy Henegar, Lambert Assoumou, Stephane De Wit, Margaret Johnson, Eugenia Quiros Roldan, Leigh Ragone, Bryn Jones, Jean van Wyk, Michael Aboud, Carl Fletcher, Annie Duffy,Anton Pozniak,Vani Vannappagari.
HIV Medicine - Final Manuscript
Title: Effectiveness and safety of two-drug regimens containing an integrase inhibitor and reverse transcriptase inhibitor in a cohort of virologically suppressed people with HIV: Data from the COMBINE-2 study
Authors: Cristina Mussini, Cassidy Henegar, Lambert Assoumou, Stephane de Wit, Margaret Johnson, Eugenia Quiros-Roldan, Chris Kenyon, Colin Deschanvres, David Zucman, Frank Post, Roya Movahedi, Laura Comi, Julie Fox, Geoffrey Liegeon, Charlotte Martin, Jonathan Edwards, Giorgio Tiecco, Marc Delforge, Leigh Ragone, Bryn Jones, Jean van Wyk, Michael Aboud, Carl Fletcher, Anton Pozniak, Vani Vannappagari
